EUCTR2007-001705-21-ITActive, not recruitingNot Applicable
Phase II study to evaluate hepatic function and clinical aspects in patients with severe hepatic cirrhosis treated with multiple cycle of stem cells mobilisation by G-CSF administration. - ND
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 sitesStarted: April 17, 2007Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •AGE 18-80 YEARS Informative consenst availability in absence of psychiatric disease Diagnosis of hepatic cirrhosis viral, alcoholic, metabolic, cryptologic Severe hepatic dysfunction Child Puogh score 8, MELD 15
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •List in orthotopic liver transplantation Drugs allergy Asthma HIV positivity Pregnancy Digestive haemorrhage by portal hypertension within 7 days Acute infection Acute CID Active neoplasm Spleen diameter major then 18 cm
Investigators
Similar Trials
Recruiting
Phase 2
To evaluate the impact of PET scan based radiotherapy planning for cervical cancer in Indian women.CTRI/2016/05/006924Department of Biotechnology Government of India60
Active, not recruiting
Not Applicable
Ensayo clínico Fase II para evaluar la actividad del régimen de alternancia semanal del tratamiento con Temozolomida en carcinomatosis leptomeníngea en tumores sólidos de mama, de pulmón de célula no pequeña y melanoma”Tratamiento con Temozolomida en carcinomatosis leptomeningea en tumores sólidos de mama, de pulmón de célula no pequeña y melanomaEUCTR2005-005143-26-ESGrupo GENOM
Active, not recruiting
Not Applicable
Ensayo clínico Fase II para evaluar la eficacia y seguridad de la aplicación de Células Progenitoras de Médula Ósea Autóloga expandidas en el tratamiento quirúrgico de pseudoartrosis no hipertróficas de fémur, tibia y húmero, tras un primer fracaso terapéutico.Pseudoartrosis no hipertróficas de fémur, tibia y húmero, tras un primer fracaso terapéuticoMedDRA version: 13Level: LLTClassification code 10017088Term: Fractura no consolidadaEUCTR2010-022909-18-ESHospital General de L?Hospitalet
Active, not recruiting
Not Applicable
Phase II study evaluating the toxicity and activity of the combination lapatinib + capecitabine in elderly patients aged 70 and over with metastatic breast cancer over expressing HER2ocally advanced or metastatic breast cancer over expressing HER2 and = 70 years oldMedDRA version: 12.0Level: LLTClassification code 10055113Term: Breast cancer metastaticMedDRA version: 12.0Level: LLTClassification code 10048406Term: Breast cancer aggravatedEUCTR2009-015981-73-FRFNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer)
Not yet recruiting
Phase 2
Human studies to evaluate the effect and safety of passion fruit peel extract on reducing high blood pressureEssential (primary) hypertensionRBR-42nhd6Conselho Nacional de Desenvolvimento Científico e Tecnológico